l-Glutamine and Whole Protein Restore First-Phase Insulin Response and Increase Glucagon-Like Peptide-1 in Type 2 Diabetes Patients

類似資料

• Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in type 2 diabetes patients
  著者:: Samocha-Bonet, Dorit, 等
  出版事項: (2011)
• Effects of Intraduodenal Glutamine on Incretin Hormone and Insulin Release, the Glycemic Response to an Intraduodenal Glucose Infusion, and Antropyloroduodenal Motility in Health and Type 2 Diabetes
  著者:: Chang, Jessica, 等
  出版事項: (2013)
• Glycemic effects and safety of L-Glutamine supplementation with or without sitagliptin in type 2 diabetes patients-a randomized study.
  著者:: Dorit Samocha-Bonet, 等
  出版事項: (2014-01-01)
• Glycemic Effects and Safety of L-Glutamine Supplementation with or without Sitagliptin in Type 2 Diabetes Patients—A Randomized Study
  著者:: Samocha-Bonet, Dorit, 等
  出版事項: (2014)
• Oral Glutamine Increases Circulating GLP-1, Glucagon and Insulin Levels in Lean, Obese and Type 2 Diabetic Subjects
  著者:: Greenfield, Jerry R, 等
  出版事項: (2008)